Cargando…
Osmotic release oral system-methylphenidate improves neural activity during low reward processing in children and adolescents with attention-deficit/hyperactivity disorder()
Attention-deficit/hyperactivity disorder (ADHD) is neurobehavioral disorder characterized by inattention, hyperactivity/impulsivity and impaired reward system function, such as delay aversion and low reward sensitivity. The pharmacological treatment for ADHD includes methylphenidate (MPH), or osmoti...
Autores principales: | Mizuno, Kei, Yoneda, Tetsuya, Komi, Masanori, Hirai, Toshinori, Watanabe, Yasuyoshi, Tomoda, Akemi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777787/ https://www.ncbi.nlm.nih.gov/pubmed/24179790 http://dx.doi.org/10.1016/j.nicl.2013.03.004 |
Ejemplares similares
-
Low putamen activity associated with poor reward sensitivity in childhood chronic fatigue syndrome
por: Mizuno, Kei, et al.
Publicado: (2016) -
Bayesian dynamical system analysis of the effects of methylphenidate in children with attention-deficit/hyperactivity disorder: a randomized trial
por: Cai, Weidong, et al.
Publicado: (2023) -
Methylphenidate remediates aberrant brain network dynamics in children with attention-deficit/hyperactivity disorder: A randomized controlled trial
por: Mizuno, Yoshifumi, et al.
Publicado: (2022) -
Advanced Test of Attention in Children with Attention-Deficit/Hyperactivity Disorder in Japan for Evaluation of Methylphenidate and Atomoxetine Effects
por: Fujioka, Toru, et al.
Publicado: (2016) -
Methylphenidate use in children with attention deficit hyperactivity disorder
por: Machado, Felipe Salles Neves, et al.
Publicado: (2015)